Evidence map›Paper›PMID 24632738›Full record

ArticlePloS one2014

A population of Langerin-positive dendritic cells in murine Peyer's patches involved in sampling β-glucan microparticles.

Magdia De Jesus, Gary R Ostroff, Stuart M Levitz, Toni R Bartling, Nicholas J Mantis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 59 citations in OpenAlex.

  1. Non-Proliferative Immune Restoration byJournal of microbiology and biotechnology · 2026
    Article
  2. Domestication of a WildJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Article
  4. An update on oral drug deliveryActa pharmaceutica Sinica. B · 2021
    Review
  5. Review
  6. Article
  7. Article
  8. Effects of food-borne nanomaterials on gastrointestinal tissues and microbiota.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Polymeric nanoparticle technologies for oral drug delivery.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Magdia De JesusDivision of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, New York, United States of America.
Gary R OstroffProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Stuart M LevitzDepartment of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Toni R BartlingCollege of Nanoscale Sciences and Engineering, State University of New York, Albany, New York, United States of America.
Nicholas J MantisDivision of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, New York, United States of America; Department of Biomedical Sciences, University at Albany, Albany, New York, United States of America.
University of Massachusetts Chan Medical School · USNew York State Department of Health · USUniversity at Albany, State University of New York · USWadsworth Center · US

Funding

ROLE OF MACROPHAGES IN CRYPTOCOCCAL INFECTIONSR01AI025780 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEVITZ, STUART MICHAEL · 1987 to 2019
$7.1M
Oral Delivery Vehicles for RNAi TherapiesR01DK085753 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 2009 to 2013
$5.9M
Intestinal P450 and Xenobiotic MetabolismR01GM082978 · NIGMS · WADSWORTH CENTER · PI ZHANG, QING-YU · 2008 to 2018
$3.3M
Glucan Particles as a Vaccine Platform for Protective ImmunityR01AI102618 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEVITZ, STUART MICHAEL · 2013 to 2016
$2.1M
Epithelial Glycoconjugates as Barriers against Enteric InfectionsR01HD061916 · NICHD · WADSWORTH CENTER · PI BRY, LYNN, MANTIS, NICHOLAS J. · 2009 to 2013
$1.9M
Interactions of pDCs with AspergilusR01HL112671 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEVITZ, STUART MICHAEL · 2013 to 2016
$1.7M
Enhancing TB vaccine with gene silencingR21AI094074 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LEE, JINHEE · 2012 to 2013
$452k
NHLBI NIH HHS HL112671NHLBI NIH HHS R01 HL112671NIAID NIH HHS 1R21AI094074NIAID NIH HHS AI025780NIAID NIH HHS AI102618NIAID NIH HHS R01 AI025780NIAID NIH HHS R01 AI102618NIAID NIH HHS R21 AI094074NICHD NIH HHS HD061916NICHD NIH HHS R01 HD061916NIDDK NIH HHS R01 DK085753NIDDK NIH HHS R01DK085753NIGMS NIH HHS GM082978NIGMS NIH HHS R01 GM082978
6 · The paper itself

Abstract

Glucan particles (GPs) are 2-4 μm hollow, porous shells composed of 1,3-β-D-glucan that have been effectively used for oral targeted-delivery of a wide range of payloads, including small molecules, siRNA, DNA, and protein antigens. While it has been demonstrated that the transepithelial transport of GPs is mediated by Peyer's patch M cells, the fate of the GPs once within gut-associated lymphoid tissue (GALT) is not known. Here we report that fluorescently labeled GPs administered to mice by gavage accumulate in CD11c+ DCs situated in Peyer's patch sub-epithelial dome (SED) regions. GPs appeared in DCs within minutes after gavage and remained within the SED for days afterwards. The co-administration or sequential administration of GPs with differentially labeled GPs or poly(lactic-co-glycolic acid) nanoparticles demonstrated that the SED DC subpopulation in question was capable of internalizing particles of different sizes and material compositions. Phenotypic analysis identified the GP-containing DCs as being CD8α- and CD11blo/-, suggesting they are the so-called myeloid and/or double negative (DN) subset(s) of PP DCs. A survey of C-type lectin receptors (CLRs) known to be expressed by leukocytes within the intestinal mucosa revealed that GP-containing SED DCs were positive for Langerin (CD207), a CLR with specificity for β-D-glucan and that has been shown to mediate the internalization of a wide range of microbial pathogens, including bacteria, viruses and fungi. The presence of Langerin+ DCs in the SED as determined by immunofluorescence was confirmed using Langerin E-GFP transgenic mice. In summary, our results demonstrate that following M cell-mediated transepithelial transport, GPs (and other micro/nanoparticles) are sampled by a population of SED DCs distinguished from other Peyer's patch DC subsets by their expression of Langerin. Future studies will be aimed at defining the role of Langerin in antigen sampling and antigen presentation within the context of the GALT.

Indexed as

Animalsbeta-GlucansCells, CulturedDendritic CellsFemaleLactic AcidMiceMice, Inbred BALB CMice, Inbred C57BLNanoparticlesPeyer's PatchesPolyglycolic AcidPolylactic Acid-Polyglycolic Acid Copolymerbeta-GlucansLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid Copolymer

Identifiers

PMID24632738
PMCPMC3954581
OpenAlexW2096092034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.